Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
RESEARCH TOOLSreports
Vertex Pharmaceuticals (VX1) Ownership Overview
0.22% Insiders
37.86%
Mutual Funds
5.24% Other Institutional Investors
25.74% ETFs
30.94% Public Companies and
Individual Investors
The ownership structure of Vertex Pharmaceuticals (DE:VX1) stock is a mix of institutional, retail, and individual investors. Approximately 68.84% of the company’s stock is owned by Institutional Investors, 0.22% is owned by Insiders, and 30.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 07, 2025 | xxxxxxxxxxxxx | $3895768 | |
Aug 07, 2025 | xxxxxxxxxxxxx | $1948416 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $24486 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $44520 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $107293 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $227942 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,389,272 | Institution | 8.33% | 9,840,968,765 | |
| 18,257,282 | Institution | 7.11% | 8,399,974,618 | |
| 14,454,201 | Institution | 5.63% | 6,650,218,884 | |
| 11,996,217 | Institution | 4.67% | 5,519,327,483 | |
| 9,669,567 | Institution | 3.77% | 4,448,861,411 | |
| 8,813,302 | Institution | 3.43% | 4,054,903,304 | |
| 4,925,687 | Institution | 1.92% | 2,266,254,406 | |
| 4,448,629 | Institution | 1.73% | 2,046,765,268 | |
| 4,076,117 | Institution | 1.59% | 1,875,376,594 | |
| 4,024,523 | Institution | 1.57% | 1,851,638,763 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,257,282 | Institution | 7.11% | 8,399,974,618 | |
| 11,996,217 | Institution | 4.67% | 5,519,327,483 | |
| 4,925,687 | Institution | 1.92% | 2,266,254,406 | |
| 4,448,629 | Institution | 1.73% | 2,046,765,268 | |
| 4,076,117 | Institution | 1.59% | 1,875,376,594 | |
| 4,024,523 | Institution | 1.57% | 1,851,638,763 | |
| 3,904,210 | Institution | 1.52% | 1,796,284,075 | |
| 3,180,504 | Institution | 1.24% | 1,463,314,905 | |
| 3,146,295 | Institution | 1.23% | 1,447,575,720 | |
| 2,983,421 | Institution | 1.16% | 1,372,639,184 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Vertex Pharmaceuticals (DE:VX1)?
According to the latest TipRanks data, approximately 5.24% of the company's stock is held by institutional investors, 0.22% is held by insiders, and 30.94% is held by retail investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.24% of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.94% of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors.
Who owns the most shares of Vertex Pharmaceuticals (DE:VX1)?
Vanguard owns the most shares of Vertex Pharmaceuticals (DE:VX1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.